Alpine ImmunoSciences, L.P. is a venture capital fund based in Seattle, Washington. Its most recent Form D, filed Dec 24, 2014, reports no sales yet. The minimum investment it accepts from an outside investor is $100,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Mitchell Gold; Alpine BioVentures, GP, LLC.
- Total raised
- $0Cumulative sales reported on Form D
- Investors
- 0
- First sale
- —
- Minimum investment
- $100,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Mitchell Gold; Alpine BioVentures, GP, LLC
- Latest Form D
- Dec 24, 2014
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Alpine ImmunoSciences, L.P.
What is the minimum investment for Alpine ImmunoSciences, L.P.?
According to its latest Form D, filed Dec 24, 2014, the minimum investment Alpine ImmunoSciences, L.P. accepts from an outside investor is $100,000.
Who can invest in Alpine ImmunoSciences, L.P.?
Alpine ImmunoSciences, L.P. is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has Alpine ImmunoSciences, L.P. raised?
Alpine ImmunoSciences, L.P.'s latest Form D, filed Dec 24, 2014, reports no sales yet.
Where is Alpine ImmunoSciences, L.P. based?
Alpine ImmunoSciences, L.P. is based in Seattle, Washington.
Size compared with every venture capital fund
This fund hasn't reported any sales yet.